<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Japan Multicenter Investigation of <z:chebi fb="0" ids="35674">Antihypertensive</z:chebi> Treatment for <z:hpo ids='HP_0000112'>Nephropathy</z:hpo> in Diabetics (J-MIND) study was conducted to evaluate the effect of <z:chebi fb="1" ids="7565">nifedipine</z:chebi> retard or enalapril on <z:hpo ids='HP_0000112'>nephropathy</z:hpo> in hypertensive patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>A total of 436 patients with normoalbuminuria [urinary albumin excretion rate (AER) &lt;30 mg/day] or <z:mp ids='MP_0002959'>microalbuminuria</z:mp> [AER: 30-300 mg/day] were randomized to receive <z:chebi fb="1" ids="7565">nifedipine</z:chebi> retard or enalapril and were followed for 24 months </plain></SENT>
<SENT sid="2" pm="."><plain>There were no differences in baseline characteristics between the two groups (the mean AER was 45 and 42 mg/day, respectively) </plain></SENT>
<SENT sid="3" pm="."><plain>Intent-to-treat analysis showed no significant difference in AER after 2 years, although the mean AER increased to 64 and 74 mg/day in the <z:chebi fb="1" ids="7565">nifedipine</z:chebi> retard and enalapril groups, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>The AER increased in patients with normoalbuminuria, whereas it did not change in those with <z:mp ids='MP_0002959'>microalbuminuria</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>There were no differences between the two groups with respect to progression from normoalbuminuria to <z:mp ids='MP_0002959'>microalbuminuria</z:mp>, progression from <z:mp ids='MP_0002959'>microalbuminuria</z:mp> to overt <z:hpo ids='HP_0000093'>proteinuria</z:hpo>, and regression from <z:mp ids='MP_0002959'>microalbuminuria</z:mp> to normoalbuminuria </plain></SENT>
<SENT sid="6" pm="."><plain>The incidence of cardiovascular events was also similar in both groups </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, <z:chebi fb="1" ids="7565">nifedipine</z:chebi> retard and enalapril had a similar effect on <z:hpo ids='HP_0000112'>nephropathy</z:hpo> in hypertensive type 2 diabetic patients without overt <z:hpo ids='HP_0000093'>proteinuria</z:hpo> </plain></SENT>
</text></document>